Search Results 371-380 of 16050 for SC

  1. Mayo Clinic Health System now offering Saturday appointments for cervical cancer screening

    Sc., a physician assistant who leads project efforts. "We also know that finding time to schedule a cervical cancer screening can be tough for many women ...

  2. Publications - Pablo Moreno Franco, M.D. - Mayo Clinic

    ... SC, Pollock BD. Exploring COVID-19 census burdens by US hospital characteristics: Implications of quality reporting at rural and critical access hospitals ...

  3. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    MTX: ≥15 mg/week subcutaneous (SC) or intramuscular (IM). Note: Oral MTX ... At least one 4-week induction regimen of adalimumab (one 160 mg SC dose at Week 0, ...

  4. Out-of-network noncontracted plans - Mayo Clinic

    SC: Mayo Clinic Breadcrumb. Home · Insurance & Billing · Insurance · Insurance types. Sections Insurance types. Before arriving. Collapse Before arriving.

  5. Jaw surgery - Doctors & Departments - Mayo Clinic

    Bagheri SC, ed. Mandibular orthognathic surgery. In: Clinical Review of Oral and Maxillofacial Surgery. 3rd ed. Elsevier; 2025. https://www.clinicalkey.com ...

  6. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

    ... (SC) every 8 Weeks (q8w) 90 mg ustekinumab maintenance therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  7. A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    Participants will be randomized to receive either lebrikizumab or placebo subcutaneously (SC) every 4 weeks. Participation eligibility. Participant ...

  8. Tetanus - Symptoms and causes - Mayo Clinic

    Learn about treatment of the serious bacterial infection commonly known as lockjaw and the vaccines that prevent it.

  9. Publications - Sonya Makhni, M.D., M.S. - Mayo Clinic

    Rojas JC, Fahrenbach J, Makhni S, Cook SC, Williams JS, Umscheid CA, Chin MH. Framework for Integrating Equity Into Machine Learning Models: A Case Study ...

  10. A Study to Evaluate the Safety and Effectiveness of Lanadelumab to Prevent Acute Attacks of Non-histaminergic Angioedema - Mayo Clinic

    The purpose of this study is to evaluate the long-term safety and effectiveness of repeated subcutaneous (SC) administration of lanadelumab in adults with ...